Targeted Therapy [topp]    
Advanced [qlco]    
Cancer, Gallbladder [neop]    
Cholangiocarcinoma [neop]    
aggressive [mobd]    
Biology [bmod]    
elicit [qlco]    
Response [orga]    
Signal [phpr]    
Phase 1 Trial [resa]    
Purpose [ftcn]    
Patients [podg]    
Advanced [qlco]    
Cholangiocarcinoma [neop]    
gall bladder carcinoma [neop]    
Few [qnco]    
Therapeutic [topp]    
Options [ftcn]    
RELAPSED DISEASE [dsyn]    
Methods [inpr]    
GIVEN [cnce]    
Poor prognosis [fndg]    
Availability [ftcn]    
novel Therapies [topp]    
Targeted [ftcn]    
Characteristics [qlco]    
gall bladder carcinoma [neop]    
Cholangiocarcinoma [neop]    
Patients [podg]    
Treated [ftcn]    
PHASE I TRIAL [resa]    
Targeted [ftcn]    
Agent [chvf]    
Therapies [topp]    
Treated [ftcn]    
Patients [podg]    
gall bladder carcinoma [neop]    
Cholangiocarcinoma [neop]    
Median [spco]    
YEARS [tmco]    
Stable Disease [fndg]    
Partial Response [fndg]    
Protocols [inpr]    
Hepatic Arterial Infusion [topp]    
Drug [phsu]    
Anti-Angiogenesis [topp]    
Novel [qlco]    
MAPK/ERK Kinase Inhibitor [phsu]    
Median [spco]    
Progression-Free Survival [qnco]    
PHASE I TRIAL [resa]    
2 Months [tmco]    
CI [geoa]    
3 Months [tmco]    
3 Months [tmco]    
4 - 6 [qnco]    
3 Months [tmco]    
Second [qnco]    
Last [qlco]    
Line [spco]    
FDA [hcro]    
Approved [qlco]    
therapy [ftcn]    
univariate analysis [resa]    
Metastatic [ftcn]    
Sites [spco]    
elevated Aminotransferase [fndg]    
ALT [neop]    
Serum Creatinine [lbpr]    
short [qlco]    
Progression-Free Survival [qnco]    
Mutation Analysis [lbpr]    
Revealed [qlco]    
Mutation [genf]    
K-ras Oncogene [gngm]    
Patients [podg]    
Stable Disease [fndg]    
Partial Response [fndg]    
Seen [qlco]    
Hepatic Arterial Infusion [topp]    
inhibitors [chvf]    
Angiogenesis [ortf]    
Conclusions [idcn]    
Progression-Free Survival [qnco]    
PHASE I TRIAL [resa]    
Second [qnco]    
Last [qlco]    
Line [spco]    
therapy [ftcn]    
FDA [hcro]    
Approved [qlco]    
Agent [chvf]    
GIVEN [cnce]    
Advanced [qlco]    
Setting [ftcn]    
Targeted [ftcn]    
Agent [chvf]    
CLINICAL TRIALS [resa]    
Setting [ftcn]    
Therapeutic [topp]    
Options [ftcn]    
Patients [podg]    
